The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zinc Finger Nuclease Technology-Global Market Insights and Sales Trends 2024
Synopsis
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.
The global Zinc Finger Nuclease Technology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Zinc Finger Nuclease Technology in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory and Academic and Research Institutes, are propelling Zinc Finger Nuclease Technology market. Cell Line Engineering, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Zinc Finger Nuclease Technology market, driven by demand from China, the second largest economy with some signs of stabilising, the Zinc Finger Nuclease Technology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zinc Finger Nuclease Technology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zinc Finger Nuclease Technology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zinc Finger Nuclease Technology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zinc Finger Nuclease Technology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zinc Finger Nuclease Technology covered in this report include Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific and Gilead, etc.
The global Zinc Finger Nuclease Technology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
Global Zinc Finger Nuclease Technology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zinc Finger Nuclease Technology market, Segment by Type:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Global Zinc Finger Nuclease Technology market, by Application
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Zinc Finger Nuclease Technology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.
The global Zinc Finger Nuclease Technology market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Zinc Finger Nuclease Technology in various end use industries. The expanding demands from the Biotechnology Companies, Pharmaceutical Companies, Hospital Laboratory and Diagnostic Laboratory and Academic and Research Institutes, are propelling Zinc Finger Nuclease Technology market. Cell Line Engineering, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animal Genetic Engineering segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Zinc Finger Nuclease Technology market, driven by demand from China, the second largest economy with some signs of stabilising, the Zinc Finger Nuclease Technology market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zinc Finger Nuclease Technology, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zinc Finger Nuclease Technology market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zinc Finger Nuclease Technology market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zinc Finger Nuclease Technology sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zinc Finger Nuclease Technology covered in this report include Sigma-Aldrich, Sangamo Therapeutics, Labomics, Thermo Fisher Scientific and Gilead, etc.
The global Zinc Finger Nuclease Technology market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead
Global Zinc Finger Nuclease Technology market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zinc Finger Nuclease Technology market, Segment by Type:
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other
Global Zinc Finger Nuclease Technology market, by Application
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Zinc Finger Nuclease Technology companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Zinc Finger Nuclease Technology
1.1 Zinc Finger Nuclease Technology Market Overview
1.1.1 Zinc Finger Nuclease Technology Product Scope
1.1.2 Zinc Finger Nuclease Technology Market Status and Outlook
1.2 Global Zinc Finger Nuclease Technology Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Zinc Finger Nuclease Technology Market Size by Region (2018-2029)
1.4 Global Zinc Finger Nuclease Technology Historic Market Size by Region (2018-2023)
1.5 Global Zinc Finger Nuclease Technology Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Zinc Finger Nuclease Technology Market Size (2018-2029)
1.6.1 North America Zinc Finger Nuclease Technology Market Size (2018-2029)
1.6.2 Europe Zinc Finger Nuclease Technology Market Size (2018-2029)
1.6.3 Asia-Pacific Zinc Finger Nuclease Technology Market Size (2018-2029)
1.6.4 Latin America Zinc Finger Nuclease Technology Market Size (2018-2029)
1.6.5 Middle East & Africa Zinc Finger Nuclease Technology Market Size (2018-2029)
2 Zinc Finger Nuclease Technology Market by Type
2.1 Introduction
2.1.1 Cell Line Engineering
2.1.2 Animal Genetic Engineering
2.1.3 Plant Genetic Engineering
2.1.4 Other
2.2 Global Zinc Finger Nuclease Technology Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Zinc Finger Nuclease Technology Historic Market Size by Type (2018-2023)
2.2.2 Global Zinc Finger Nuclease Technology Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Zinc Finger Nuclease Technology Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Zinc Finger Nuclease Technology Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Zinc Finger Nuclease Technology Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Zinc Finger Nuclease Technology Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Zinc Finger Nuclease Technology Revenue Breakdown by Type (2018-2029)
3 Zinc Finger Nuclease Technology Market Overview by Application
3.1 Introduction
3.1.1 Biotechnology Companies
3.1.2 Pharmaceutical Companies
3.1.3 Hospital Laboratory and Diagnostic Laboratory
3.1.4 Academic and Research Institutes
3.1.5 Others
3.2 Global Zinc Finger Nuclease Technology Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Zinc Finger Nuclease Technology Historic Market Size by Application (2018-2023)
3.2.2 Global Zinc Finger Nuclease Technology Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Zinc Finger Nuclease Technology Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Zinc Finger Nuclease Technology Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Zinc Finger Nuclease Technology Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Zinc Finger Nuclease Technology Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Zinc Finger Nuclease Technology Revenue Breakdown by Application (2018-2029)
4 Zinc Finger Nuclease Technology Competition Analysis by Players
4.1 Global Zinc Finger Nuclease Technology Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zinc Finger Nuclease Technology as of 2022)
4.3 Date of Key Players Enter into Zinc Finger Nuclease Technology Market
4.4 Global Top Players Zinc Finger Nuclease Technology Headquarters and Area Served
4.5 Key Players Zinc Finger Nuclease Technology Product Solution and Service
4.6 Competitive Status
4.6.1 Zinc Finger Nuclease Technology Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sigma-Aldrich
5.1.1 Sigma-Aldrich Profile
5.1.2 Sigma-Aldrich Main Business
5.1.3 Sigma-Aldrich Zinc Finger Nuclease Technology Products, Services and Solutions
5.1.4 Sigma-Aldrich Zinc Finger Nuclease Technology Revenue (US$ Million) & (2018-2023)
5.1.5 Sigma-Aldrich Recent Developments
5.2 Sangamo Therapeutics
5.2.1 Sangamo Therapeutics Profile
5.2.2 Sangamo Therapeutics Main Business
5.2.3 Sangamo Therapeutics Zinc Finger Nuclease Technology Products, Services and Solutions
5.2.4 Sangamo Therapeutics Zinc Finger Nuclease Technology Revenue (US$ Million) & (2018-2023)
5.2.5 Sangamo Therapeutics Recent Developments
5.3 Labomics
5.3.1 Labomics Profile
5.3.2 Labomics Main Business
5.3.3 Labomics Zinc Finger Nuclease Technology Products, Services and Solutions
5.3.4 Labomics Zinc Finger Nuclease Technology Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Zinc Finger Nuclease Technology Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Zinc Finger Nuclease Technology Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Gilead
5.5.1 Gilead Profile
5.5.2 Gilead Main Business
5.5.3 Gilead Zinc Finger Nuclease Technology Products, Services and Solutions
5.5.4 Gilead Zinc Finger Nuclease Technology Revenue (US$ Million) & (2018-2023)
5.5.5 Gilead Recent Developments
6 North America
6.1 North America Zinc Finger Nuclease Technology Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Zinc Finger Nuclease Technology Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Zinc Finger Nuclease Technology Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Zinc Finger Nuclease Technology Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Zinc Finger Nuclease Technology Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Zinc Finger Nuclease Technology Market Dynamics
11.1 Zinc Finger Nuclease Technology Industry Trends
11.2 Zinc Finger Nuclease Technology Market Drivers
11.3 Zinc Finger Nuclease Technology Market Challenges
11.4 Zinc Finger Nuclease Technology Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
